Trials / Active Not Recruiting

Active Not RecruitingNCT06481345

Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)

Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele

Status: Active Not Recruiting
Phase: —
Study type: Observational
Enrollment: 300 (estimated)

Sponsor: University Hospital, Brest · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: —

Summary

Retrospective study assessing the impact of IDH1/2, SRSF2 or SF3B1 mutations on event free survival of MPN patients

Detailed description

Patients with a diagnosis of MPN and a mutation of IDH1/2, SRSF2 or SF3B1 will be included. Clinical and biological characterisation at diagnosis, as well as evlution will be recorded. Event free survival will be assessed in each group (event = thrombosis, transformation to mylofibrosis/acute leukemia, death).

Conditions

Myeloproliferative Disorders

Timeline

Start date: 2024-06-25
Primary completion: 2026-05-31
Completion: 2026-05-31
First posted: 2024-07-01
Last updated: 2024-07-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06481345. Inclusion in this directory is not an endorsement.